Tirzepatide
| Lub npe dav: | Tirzepatide |
| Cas No.: | 2023788-19-2 |
| Molecular Formula: | C225H348N48O68 |
| Molecular Luj: | 4813.45 g / mol |
| Ib ntus: | H-Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu -(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Qhov tsos: | Dawb hmoov |
| Daim ntawv thov: | Tirzepatide yog ib qho tshuaj uas tau kawm txog nws txoj kev siv hauv kev kho mob ntshav qab zib hom 2. Nws belongs rau ib chav kawm ntawm cov tshuaj hu ua diglucose-dependent insulinotropic peptide (GIP) thiab glucagon-zoo li peptide-1 (GLP-1) receptor agonists. Tezepatide ua haujlwm los ntawm kev txhawb nqa GIP thiab GLP-1 receptors hauv lub cev. Cov receptors no ua lub luag haujlwm tseem ceeb hauv kev tswj cov ntshav qab zib thiab cov metabolism. Los ntawm kev ua kom cov receptors no, tezepatide nce kev tsim cov tshuaj insulin thiab txo qhov tso tawm ntawm glucagon, ib yam tshuaj uas nce ntshav qab zib. Nws kuj ua rau lub plab khoob thiab pab tswj cov ntshav qab zib. Kev sim tshuaj ntsuam xyuas tau pom tias tilsiparatide tuaj yeem tswj cov ntshav qab zib kom zoo hauv cov neeg mob ntshav qab zib hom 2. Nws kuj tau pom los txhawb kev poob phaus, uas yog ib qho txiaj ntsig ntxiv rau ntau tus neeg mob ntshav qab zib hom 2 uas muaj teeb meem tswj lub cev hnyav. Ib qho ntawm qhov zoo ntawm tezeparatide yog nws qhov kev siv tshuaj ib zaug ib lub lim tiam, uas yuav ua rau kom yooj yim dua thiab ua raws li kev kho mob. Qhov no tej zaum yuav muaj txiaj ntsig tshwj xeeb rau cov tib neeg uas muaj teeb meem ua raws li lub sijhawm noj tshuaj txhua hnub lossis leej twg nyiam txoj kev npaj kho mob ntau dua. Nws yuav tsum raug sau tseg tias tilsiparatide tseem nyob rau theem kev tshawb nrhiav thiab tseem tsis tau pom zoo siv los ntawm cov koom haum tswj hwm. Kev tshawb fawb ntxiv yog xav tau los txiav txim siab nws txoj kev nyab xeeb mus sij hawm ntev thiab ua haujlwm tau zoo thiab txheeb xyuas cov kev mob tshwm sim uas yuav tshwm sim. Hauv cov ntsiab lus, tilsiparatide yog cov tshuaj tshiab tau tshawb xyuas rau kev kho mob ntshav qab zib hom 2. Nws ob txoj haujlwm ntawm GIP thiab GLP-1 receptors muaj peev xwm txhim kho glycemic tswj thiab poob phaus. Txawm li cas los xij, xav tau kev tshawb fawb ntxiv ua ntej tilsiparatide tuaj yeem pom zoo los ua kev kho mob rau cov neeg mob ntshav qab zib hom 2. |
| Pob: | aluminium foil hnab los yog txhuas TIN lossis raws li tus neeg siv khoom xav tau |
| 1 | Cov kws tshaj lij rau peptide APIs los ntawm Tuam Tshoj. |
| 2 | 16 cov kab ntau lawm uas muaj peev xwm loj txaus nrog cov nqi sib tw |
| 3 | DMF muaj nrog cov ntaub ntawv txhim khu kev qha tshaj plaws. |
A: Yog lawm, peb tuaj yeem ntim raws li koj xav tau.
A: LC pom thiab TT ua ntej lub sijhawm them nyiaj nyiam.
A: Yog, thov muab koj cov lus qhia zoo, peb yuav kuaj nrog peb R & D thiab sim ua kom haum koj cov lus qhia zoo.
Sau koj cov lus ntawm no thiab xa tuaj rau peb
